Filing Details

Accession Number:
0001127602-14-032948
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-20 09:32:28
Reporting Period:
2014-11-18
Filing Date:
2014-11-20
Accepted Time:
2014-11-20 09:32:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
794172 Meridian Bioscience Inc VIVO In Vitro & In Vivo Diagnostic Substances (2835) 310888197
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1224663 Melissa Lueke 3471 River Hills Drive
Cincinnati OH 45244
Exec Vp, Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-11-18 10,500 $7.28 139,861 No 4 M Direct
Common Stock Disposition 2014-11-18 6,713 $16.20 133,148 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2014-11-18 10,500 $0.00 10,500 $7.28
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-12-07 No 4 M Direct
Footnotes
  1. These options became fully vested in November 2008.